Read research highlights just released from the ASCO20 Virtual Scientific Program. They include studies on immunotherapy for metastatic colorectal cancer and gestational trophoblastic disease, maintenance therapy for advanced bladder cancer, the potential of precision medicine for childhood cancers, and targeted therapy after surgery for EGFR-positive non-small cell lung cancer. Read More >>
bladder cancer
May 28, 2020 · Brielle Gregory, ASCO staff
May 28, 2020 · Brielle Gregory, ASCO staff
Lea los puntos destacados de la investigación del programa científico virtual ASCO20 que se acaban de publicar. Incluyen estudios sobre inmunoterapia para el cáncer colorrectal metastásico y la enfermedad trofoblástica gestacional, terapia de mantenimiento para el cáncer de vejiga avanzado, el potencial de la medicina de precisión para el cáncer infantil y la terapia dirigida después de la cirugía por EGFR (receptor del factor de crecimiento epidérmico), positivo de cáncer de pulmón de células no pequeñas. Read More >>
May 5, 2020 · Brielle Gregory, ASCO staff
In this Clinical Trials in Genitourinary Cancers series podcast, experts discuss 3 clinical trials aiming to identify new treatments for prostate, bladder, and kidney cancers. Read More >>
February 13, 2020 · Brielle Gregory, ASCO staff
In the first podcast of the Clinical Trials in Genitourinary Cancers series, experts discuss 3 clinical trials that are currently exploring new ways of treating kidney, bladder, and prostate cancers. Read More >>
June 3, 2019 · Greg Guthrie, ASCO staff
The ASCO Annual Meeting is where many new cancer research findings are announced. Today’s key research highlights include minimally invasive surgery for liver metastases in colorectal cancer, expanding clinical trial eligibility criteria for non-small cell lung cancer, and a new targeted therapy for advanced bladder cancer. Read More >>
Pages
- « first page
- ‹ previous page
- page 1
- page 2
- 3 current page
- page 4
- next page ›
- last page »